FIFTH THIRD BANCORP
BankPosition in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 35527
CINCINNATI, OH
Position in ARWR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,488,826
+$391,700 QoQ
Shares Held
30,534
-8.7% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#179
of 497 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $201,859,483 across 149 Biotechnology names. ARWR ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,898 | $40,681,193 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,244 | $18,234,803 | |
| 3 | TECH |
BIO-TECHNE Corp
|
117,371 | $8,292,261 | |
| 4 | VCEL |
Vericel Corp
|
185,051 | $8,232,918 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
65,659 | $7,529,117 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
95,681 | $7,488,951 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
87,238 | $6,497,486 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
193,236 | $6,452,150 |
All Filings in ARWR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,488,826 | 30,534 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $2,097,126 | 33,447 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $80,796 | 1,217 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $39,663 | 1,150 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $21,567 | 1,365 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $6,000 | 471 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $25,756 | 1,370 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $25,510 | 1,317 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $30,824 | 1,186 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $23,795 | 832 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $35,557 | 1,162 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $26,547 | 988 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $16,617 | 466 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $3,556 | 140 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $13,912 | 343 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $13,814 | 418 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $19,471 | 553 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $9,887 | 215 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $28,973 | 437 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $19,103 | 306 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $14,079 | 170 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $8,620 | 130 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $10,358 | 135 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,076 | 25 | Shares | Defined | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||